US$ 26.80
dual glp 1 and gip receptor agonist Free Comparison Chart: GLP-1 GIP/GLP-1 Agonists for Type 2 Diabetes π Link in bio #FOAMed #Type2Diabetes #GLP1 Cardiorenal Outcomes With GLP-1 vs.
Description
While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss and healthy eating.
GLP-1RA only reduced the risk of nonfatal stroke

A more mindful, wellness-forward approach to GLP-1 use

95% CI 0.310.50), MACEs (aHR 0.66

In clinical practice, drug selection should therefore prioritize factors such as tolerability, safety profile, adherence, cost, and patient preference rather than expecting major differences in cardiovascular efficacy.
